{"id":6079,"date":"2024-09-03T10:19:16","date_gmt":"2024-09-03T10:19:16","guid":{"rendered":"https:\/\/demopublication.edutechy.xyz\/?page_id=6079"},"modified":"2025-04-26T10:33:27","modified_gmt":"2025-04-26T10:33:27","slug":"pharmacovigilance","status":"publish","type":"page","link":"https:\/\/sproutpublication.com\/index.php\/pharmacovigilance\/","title":{"rendered":"Pharmacovigilance"},"content":{"rendered":"

<\/span><\/div><\/div><\/div><\/div>

Pharmacovigilance<\/h4><\/div>
<\/div><\/div>

Editors:<\/strong>\u00a0Mr. Satyendra Garg, Mr. Abu Tahir, Mr. Ashutosh Jain
\nISBN:<\/strong>\u00a0978-81-978670-3-3
\nAccess:<\/strong> Closed Access
\nBinding Type:<\/strong>\u00a0Perfect Binding
\nCopyright:<\/strong>\u00a02024
\nDOI:<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/div>

About this Book<\/h2><\/div>
<\/div><\/div>

The book on “Pharmacovigilance,” overseen by editors Mr. Satyendra Garg, Mr. Abu Tahir, and Mr. Ashutosh Jain, serves as a comprehensive resource on the field of drug safety and monitoring. With contributions from esteemed academics at Rajiv Gandhi Institute of Pharmacy, AKS University, Satna (M.P.), the book covers a broad spectrum of topics crucial for understanding pharmacovigilance. Beginning with an introduction to pharmacovigilance and adverse drug reactions by Dr. Surya Prakash Gupta, the book delves into essential terminologies, drug classifications, and coding systems. It also explores the establishment of pharmacovigilance programs, vaccine safety surveillance, communication strategies, and adherence to ICH guidelines. Further chapters examine pharmacogenomics, drug safety in special populations, and the roles of CIOMS and CDSCO in India’s pharmacovigilance landscape. This book is an invaluable reference for students, researchers, and professionals dedicated to ensuring the safe use of medications.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

\n

Chapter 1: Introduction to Pharmacovigilance<\/a><\/h2>

Author: <\/strong>Dr. Surya Prakash Gupta
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: [\u2026]<\/a><\/strong><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T10:01:37+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 2: Introduction to Adverse Drug Reactions-I<\/a><\/h2>

Author: <\/strong>Mr. Prabhakar Singh Tiwari
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: [\u2026]<\/a><\/strong><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T10:01:12+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 3: Introduction to Adverse Drug Reactions-II<\/a><\/h2>

Author: <\/strong>Ms. Neha Goel
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T10:00:49+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 4: Basic Terminologies Used in Pharmacovigilance<\/a><\/h2>

Author: <\/strong>Mr. Satyendra Garg
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T10:00:24+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 5: Drug And Disease Classification<\/a><\/h2>

Author: <\/strong>Mrs. Neelam Singh
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T10:00:01+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 6: Drug Dictionaries and Coding in Pharmacovigilance<\/a><\/h2>

Author: <\/strong>Mr. Abu Tahir
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:59:33+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 7: Information Resources in Pharmacovigilance<\/a><\/h2>

Author: <\/strong>Mr. Ashutosh Jain
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:59:09+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 8: Establishing Pharmacovigilance Programme<\/a><\/h2>

Author: <\/strong>Ms. Shikha Singh
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:58:44+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 9: Vaccine Safety Surveillance<\/a><\/h2>

Author: <\/strong>Mrs. Saba Ruksaar
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:58:22+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 10: Pharmacovigilance Methods-I<\/a><\/h2>

Author: <\/strong>Dr. Surya Prakash Gupta
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: [\u2026]<\/a><\/strong><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:56:27+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 11: Pharmacovigilance Methods-II<\/a><\/h2>

Author: <\/strong>Mr. Prabhakar Singh Tiwari
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: [\u2026]<\/a><\/strong><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:56:02+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 12: Communication In Pharmacovigilance-I<\/a><\/h2>

Author: <\/strong>Ms. Neha Goel
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:55:38+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 13: Communication In Pharmacovigilance-II<\/a><\/h2>

Author: <\/strong>Mr. Satyendra Garg<\/p>\n

Volume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:55:15+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 14: Safety Data Generation<\/a><\/h2>

Author: <\/strong>Mrs. Neelam Singh
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:54:53+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 15: ICH Guidelines for Pharmacovigilance-I<\/a><\/h2>

Author: <\/strong>Mr. Abu Tahir
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:54:28+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 16: ICH Guidelines for Pharmacovigilance-II<\/a><\/h2>

Author: <\/strong>Mr. Ashutosh Jain
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:54:04+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 17: Pharmacogenomics of Adverse Drug Reactions<\/a><\/h2>

Author: <\/strong>Ms. Shikha Singh
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:53:41+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 18: Drug Safety Evaluation in Special Population<\/a><\/h2>

Author: <\/strong>Mrs. Saba Ruksaar
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: <\/strong> [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:53:21+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 19: CIOMS, CDSCO (India) And Pharmacovigilance-I<\/a><\/h2>

Author: <\/strong>Dr. Surya Prakash Gupta
\nVolume: <\/strong> 01
\nFirst Online: <\/strong>31 August [\u2026]<\/a><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:52:58+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n
\n

Chapter 20: CIOMS, CDSCO (India) And Pharmacovigilance-II<\/a><\/h2>

Author: <\/strong>Mr. Prabhakar Singh Tiwari
\nVolume: <\/strong>01
\nFirst Online: <\/strong>31 August 2024
\nPages: [\u2026]<\/a><\/strong><\/p>\n<\/div><\/div>

<\/div>
newadmin<\/a><\/span><\/span>2025-04-26T09:52:38+00:00<\/span>
Read More<\/a><\/div><\/div><\/article>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-6079","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/pages\/6079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/comments?post=6079"}],"version-history":[{"count":9,"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/pages\/6079\/revisions"}],"predecessor-version":[{"id":7395,"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/pages\/6079\/revisions\/7395"}],"wp:attachment":[{"href":"https:\/\/sproutpublication.com\/index.php\/wp-json\/wp\/v2\/media?parent=6079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}